Pharmaceutical companies spend a lot of money and resources on the medical booth exhibits that showcase their pipeline and products at key medical conferences or congresses. However, the medical communications staff that prepare and manage these booth exhibits are grappling with how to best utilize technology to produce compelling and interactive medical information displays.
Even more challenging for those who plan and oversee medical conference exhibits is balancing internal compliance requirements with current exhibit booth practices at important scientific congresses and conferences.
Best Practices, LLC conducted this benchmarking study to provide biopharma companies with insights into the current practices at medical affairs booths. In particular, this study explores what medical content companies are displaying in medical exhibit booths, how they are sharing the information (proactive vs. reactive), and how they are displaying it to HCPs attending congresses. The extensive research also looks at performance measurement, poster/investigator events and what materials MSLs are utilizing in the field.
Note: Data in this research are presented into two segments: Hematology/Oncology vs. Non-Hematology/Oncology and Size (Large vs. Small Companies).